Illumina Ethics Advisory Board

Promoting ethical and just business operations

Illumina is committed to building our company with integrity and ethical business behavior.

Since 2008, Illumina has convened an Ethics Advisory Board (EAB) to support its commitment to ethical and just business operations. The EAB meets quarterly to advise and provide recommendations regarding ethical issues involving existing, emerging, and prospective products, services, and processes both from a research and clinical perspective. This includes providing strategic advice to Illumina regarding emerging ethical issues, policies, and regulations relevant to the genomics industry.

Charmaine Royal, MS, PhD

Clement Adebamowo, BM, ChB, ScD, 
FWACS, FACS

Freda Lewis-Hall, MD, DFAPA, MFPM

Glenn Cohen, JD

Leslie Biesecker, MD

Nita Farahany, JD, PhD

Illumina ethics resources

Ethics

Access our Corporate Policies and learn more about our ethical principles and positions.

Integrity Principles

Learn how we approach all aspects of our business from a safe, ethical, and responsible standpoint.